Significantly Improved Results for Medtronic's Evolut TAVR seen in the Optimize PRO Study
At this year's EuroPCR meeting, the interim results of the Optimize PRO study of Medtronic's Evolut ™ PRO and PRO+ TAVR systems in 400 patients were presented as a Hotline Trial: permanent pacemaker rates dropped to single digits (9.2%) and the number of patients with moderate or severe paravalvular leak (PVL) was zero (78% of patients had no or only trace PVL). Moreover, the median length of ho spital stay was one day. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - May 22, 2022 Category: Cardiology Source Type: news

Chronic Total Occlusion PCI Is Getting Safer -- At Least Until the Pandemic
(MedPage Today) -- ATLANTA -- Percutaneous coronary intervention for chronic total occlusion (CTO PCI) has improved in success rates, but the pandemic might have impacted complication rates, a registry study showed. Technical and procedural... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 21, 2022 Category: Cardiology Source Type: news

Intravascular Lithotripsy May Emerge as a First-Line Therapy for Calcified Lesions in Women
“Given the established safety profile of IVL and the high rates of acute and long-term adverse events in women undergoing PCI, with or without atheroablation of calcified lesions, coronary IVL is an attractive treatment option for optimizing outcomes in our female patients,” said Alexandra Lansk y, MD, FACC, FAHA, FSCAI, FESC, Professor of Medicine (Cardiology); Director of Yale Cardiovascular Clinical Research Program, Yale University School of Medicine, New Haven, Conn. “While this is the first one-year analysis of its kind for coronary IVL, the sustained benefit in MACE at one year sug gests that IVL should be con...
Source: News from Angioplasty.Org - May 20, 2022 Category: Cardiology Source Type: news

Lithotripsy Advantage in Calcified Peripheral Vessels Holds Up at 1 Year
(MedPage Today) -- ATLANTA -- Intravascular lithotripsy (IVL) beat percutaneous transluminal angioplasty (PTA) for keeping calcified peripheral artery lesions open at 1 year, the Disrupt PAD III trial showed. Primary patency at 1 year was 80... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 19, 2022 Category: Cardiology Source Type: news

ITAL-neo Registry: Boston Scientific's ACURATE neo2 Valve Significantly Reduces Paravalvular Leak (PVL) from 1st Generation Device
The first generation TAVR exhibited a not insignificant moderate or greater paravalvular leak. By adding a taller external skirt for the newer device, the PVL was reduced from 11.2% down to 3.5%. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - May 19, 2022 Category: Cardiology Source Type: news

Medtronic Receives FDA Approval for Latest Generation Drug-Eluting Coronary Stent System
Design changes include increased catheter flexibility, an innovative dual-layer balloon technology and a lower crossing profile, leading to a 16% improvement in deliverability vs. the previous generation Resolute Onyx DES. Onyx Frontier offers a broad size matrix to treat more patients and is the only 2.0 mm DES available in the United States (similar to Resolute Onyx). Further, Onyx Frontier continues to provide 4.50-5.00 mm sizes that can be expanded to 6.00 mm - specifically designed to support extra-large vessels. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - May 13, 2022 Category: Cardiology Source Type: news

Addition of Icosapent Ethyl Cuts CV Risk in Patients With Prior PCI
THURSDAY, March 24, 2022 -- The risk for cardiovascular events is reduced in statin-treated patients with elevated triglycerides and a history of percutaneous coronary intervention (PCI) who receive icosapent ethyl, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 24, 2022 Category: Pharmaceuticals Source Type: news

Meds, Exercise Recommended for Stroke Prevention After sICAS
TUESDAY, March 22, 2022 -- For patients with symptomatic intracranial atherosclerotic arterial stenosis (sICAS), initial treatment should comprise medications and exercise, and not percutaneous transluminal angioplasty and stenting, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 22, 2022 Category: Pharmaceuticals Source Type: news

Manipal Hospitals signs up with ConnectedLife & Fitbit to monitor patients after major procedures
The digital initiative aims to use wearable technology to stay connected with patients after surgeries like total knee replacement, angioplasty, cardiac bypass surgery, and other high-risk surgeries. (Source: The Economic Times)
Source: The Economic Times - March 17, 2022 Category: Consumer Health News Source Type: news

Egg Medical raises $13M to reduce risk of X-rays on health care workers
Egg Medical Inc. announced Thursday it raised $13 million to commercialize its medical device which protects staff in X-ray labs from radiation exposure. The device, called the EggNest, reduces scatter radiation by over 90% by replacing the patient mattress with a carbon fiber platform. Scatter radiation occurs when the X-ray beam is reflected off the patients body, therefore risking physicians and staff working on procedures such as angioplasty an d stenting. Munich, Germany-based TVM Capital… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - March 3, 2022 Category: Health Management Authors: Carter Jones Source Type: news

Inspira gets state approval to perform elective angioplasties at Mullica Hill hospital
The Gloucester County hospital is one of 17 across the state to get a license to do the non-invasive procedure following a new state law enacted last year. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 20, 2022 Category: Health Management Authors: John George Source Type: news

Video: Coronary angioplasty
Coronary angioplasty and stenting open clogged heart arteries and prevent them from narrowing again. Watch this video to find out more about the procedure. (Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - September 29, 2021 Category: Consumer Health News Source Type: news

Multivessel traumatic coronary artery dissection after a motor vehicle accident with successful percutaneous coronary intervention - Pandey Y, Owen B, Birnbaum G, Tabbaa R, Hamzeh I, Lakkis N, Kayani W.
We report a case of acute left anterior descending and right coronary artery dissections after a motor vehicle accident. The musculoskeletal injuries obscured the cardiac symptom... (Source: SafetyLit)
Source: SafetyLit - July 30, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
Medtronic Prevail DCB™ Designed to Treat Complex Lesions with Superior Deliverability, Rapid Absorption of Paclitaxel DUBLIN, July 26, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE: MDT), the global leader in medical technology,... Devices, Interventional, Cardiology, Regulatory Medtronic, Prevail DCB, percutaneous coronary intervention (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 26, 2021 Category: Pharmaceuticals Source Type: news

Impact of Age Examined for Ticagrelor Monotherapy After PCI
WEDNESDAY, July 7, 2021 -- For patients undergoing percutaneous coronary intervention, ticagrelor monotherapy following three months of dual antiplatelet therapy significantly reduces clinically relevant bleeding compared with ticagrelor with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 7, 2021 Category: Pharmaceuticals Source Type: news